Zhejiang Lanyu Digital Technology
301585
BBK Test Systems
301598
MEIZHIGAO
834765
Youkeshu Technology
300209
Hangzhou Raycloud Technology Co.,Ltd
688365
CN Stock MarketDetailed Quotes
300439 Medicalsystem Biotechnology
- 11.27
- +0.10+0.90%
Market Closed Dec 20 15:00 CST
4.33BMarket Cap17.23P/E (TTM)
11.32High11.08Low34.37KlotVolume11.15Open11.17Pre Close38.63MTurnover1.18%Turnover Ratio16.87P/E (Static)383.95MShares13.2452wk High1.50P/B3.29BFloat Cap7.1552wk Low13.40Limit Up291.73MShs Float77.92Historical High8.94Limit Down2.15%Amplitude7.15Historical Low0.13Dividend TTM11.24Avg Price16.80KlotAsk1.19%Div YieldTTM100Lot Size16.89KlotBid
Medicalsystem Biotechnology Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -4.35%1.41B | -2.83%949.13M | -1.91%481.51M | -24.23%1.89B | -22.65%1.47B | -24.32%976.81M | -14.99%490.89M | 10.55%2.49B | 10.45%1.9B | 15.10%1.29B |
| Operating revenue | -4.35%1.41B | -2.83%949.13M | -1.91%481.51M | -24.23%1.89B | -22.65%1.47B | -24.32%976.81M | -14.99%490.89M | 10.55%2.49B | 10.45%1.9B | 15.10%1.29B |
| Other operating revenue | ---- | -6.93%10.52M | ---- | -32.72%11.01M | ---- | -1.52%11.3M | ---- | 20.35%16.37M | ---- | 47.50%11.48M |
| Total operating cost | -6.19%1.19B | -6.11%783.3M | -4.15%412.34M | -24.70%1.66B | -23.66%1.27B | -25.72%834.29M | -15.26%430.17M | 9.64%2.21B | 10.22%1.66B | 16.04%1.12B |
| Operating cost | -5.94%762.45M | -6.36%507.94M | -6.49%278.01M | -32.14%1.04B | -31.13%810.57M | -32.90%542.45M | -16.53%297.3M | 14.87%1.54B | 15.73%1.18B | 25.22%808.42M |
| Operating tax surcharges | -17.02%13.18M | -1.12%7.96M | 5.11%3.98M | 24.99%19.15M | 41.49%15.89M | 10.15%8.05M | 12.75%3.79M | -24.14%15.32M | -28.48%11.23M | -39.30%7.31M |
| Operating expense | -3.37%189.44M | -1.41%118.84M | 10.60%54.71M | -12.60%262.52M | -11.14%196.05M | -16.88%120.54M | -14.89%49.47M | 0.81%300.36M | 4.28%220.63M | 12.28%145.02M |
| Administration expense | -11.06%118.15M | -11.62%77.1M | -2.10%39.87M | 6.98%186.99M | 5.70%132.84M | 10.56%87.24M | -17.31%40.73M | -1.47%174.79M | -7.81%125.67M | -14.65%78.91M |
| Financial expense | -68.52%-6.46M | -146.53%-4.9M | -1,465.93%-2.53M | -135.60%-1.72M | -212.06%-3.84M | -162.82%-1.99M | -96.51%185.14K | -81.49%4.83M | -81.88%3.42M | -77.23%3.17M |
| -Interest expense (Financial expense) | -64.31%1.51M | -64.71%1.28M | -77.03%338.36K | -31.79%10.66M | -60.24%4.24M | -57.65%3.62M | -78.60%1.47M | -46.57%15.63M | -49.86%10.67M | -47.21%8.54M |
| -Interest Income (Financial expense) | 3.96%-7.85M | -9.51%-6.33M | -137.47%-2.99M | -77.71%-13.27M | -64.33%-8.18M | -54.99%-5.78M | 40.79%-1.26M | -11.57%-7.47M | -25.42%-4.97M | -36.63%-3.73M |
| Research and development | -3.27%114.75M | -2.09%76.37M | -1.05%38.3M | -12.80%149.8M | -5.75%118.63M | -2.91%78M | 9.27%38.7M | 14.00%171.78M | 14.38%125.87M | 7.48%80.34M |
| Credit Impairment Loss | -78.88%4.9M | -91.51%1.95M | -53.00%8.12M | 165.42%31.55M | 170.17%23.2M | 202.63%22.97M | 249.32%17.27M | -106.09%-48.23M | -41.18%-33.07M | -84.44%-22.38M |
| Asset Impairment Loss | -182.53%-1.6M | -238.11%-1.47M | 22.38%-747.17K | 38.69%-21.27M | 18.58%-566.92K | 37.22%-433.45K | -348.75%-962.55K | -41.77%-34.69M | 90.40%-696.26K | 90.22%-690.41K |
| Other net revenue | -40.82%35.02M | -57.46%21.34M | 2.14%15.92M | 201.47%54.68M | 17,226.97%59.17M | 1,349.88%50.17M | 42.47%15.59M | -179.45%-53.89M | 97.04%-345.46K | 186.47%3.46M |
| Fair value change income | --380.29K | --213.26K | 312.39%201.2K | ---- | ---- | ---- | --48.79K | -76.31%165.26K | --779.17K | -47.31%363.61K |
| Invest income | 38.43%14.47M | 84.99%8.53M | 157.26%1.68M | 302.09%14.93M | 2.09%10.46M | -27.27%4.61M | -132.47%-2.93M | 208.43%3.71M | 673.15%10.24M | 33.20%6.34M |
| -Including: Investment income associates | -32.68%8.84M | -37.24%4.57M | -60.95%1.04M | 233.55%16.31M | 529.48%13.12M | 501.08%7.28M | 116.92%2.66M | -220.62%-12.22M | -79.56%2.08M | -138.12%-1.82M |
| Asset deal income | 111.97%8.58K | 101.65%8.58K | 103.91%16.9K | -143.23%-782.38K | 79.57%-71.68K | -6,492.94%-519.87K | -1,915.90%-432.16K | -167.14%-321.67K | -200.01%-350.9K | -97.43%8.13K |
| Other revenue | -35.54%16.85M | -48.59%12.1M | 155.83%6.66M | 18.79%30.26M | 14.95%26.15M | 18.82%23.54M | -80.95%2.6M | -17.39%25.47M | 31.31%22.75M | 110.33%19.81M |
| Operating profit | -3.64%250.21M | -2.86%187.17M | 11.51%85.09M | 22.08%279.12M | 9.49%259.65M | 12.70%192.68M | -5.49%76.31M | 4.07%228.64M | 18.48%237.14M | 14.43%170.98M |
| Add:Non operating Income | 58.10%9.16M | 987.36%9.01M | 244.06%2.47M | 19,661.22%19.23M | 739.75%5.79M | 86.07%828.23K | 207.51%717.08K | -91.24%97.33K | -9.63%689.93K | -40.89%445.11K |
| Less:Non operating expense | 153.15%4.39M | 34.24%1.46M | 139.40%1.33M | -50.81%2.67M | -54.97%1.74M | -41.78%1.09M | -30.18%553.47K | 110.84%5.43M | 330.22%3.85M | 534.47%1.87M |
| Total profit | -3.31%254.98M | 1.19%194.71M | 12.76%86.24M | 32.41%295.68M | 12.71%263.71M | 13.49%192.42M | -4.62%76.47M | 2.32%223.31M | 16.98%233.98M | 13.13%169.55M |
| Less:Income tax cost | -21.01%31.65M | -27.80%16.38M | 19.99%8.18M | 99.86%36.18M | 16.39%40.07M | -11.64%22.69M | -44.16%6.82M | -35.54%18.1M | 3.13%34.42M | 7.02%25.68M |
| Net profit | -0.14%223.33M | 5.06%178.33M | 12.06%78.05M | 26.46%259.5M | 12.07%223.64M | 17.98%169.73M | 2.48%69.65M | 7.92%205.2M | 19.75%199.56M | 14.29%143.87M |
| Net profit from continuing operation | -0.14%223.33M | 5.06%178.33M | 12.06%78.05M | 26.46%259.5M | 12.07%223.64M | 17.98%169.73M | 2.48%69.65M | 7.92%205.2M | 19.75%199.56M | 14.29%143.87M |
| Less:Minority Profit | 83.62%-1.03M | 97.32%-137.58K | 40.63%-1.04M | -55.84%2.95M | -62.61%-6.31M | -91.95%-5.14M | -10.33%-1.76M | -37.39%6.68M | 35.34%-3.88M | 62.67%-2.68M |
| Net profit of parent company owners | -2.43%224.36M | 2.06%178.46M | 10.76%79.1M | 29.23%256.55M | 13.03%229.96M | 19.33%174.87M | 2.66%71.41M | 10.61%198.53M | 17.83%203.44M | 10.15%146.55M |
| Earning per share | ||||||||||
| Basic earning per share | -2.66%0.5844 | 1.80%0.4648 | 10.53%0.21 | 28.85%0.67 | 13.03%0.6004 | 19.34%0.4566 | 5.56%0.19 | 8.33%0.52 | 13.75%0.5312 | 4.39%0.3826 |
| Diluted earning per share | -2.66%0.5844 | 1.80%0.4648 | 10.53%0.21 | 28.85%0.67 | 13.03%0.6004 | 19.34%0.4566 | 5.56%0.19 | 8.33%0.52 | 13.75%0.5312 | 4.39%0.3826 |
| Other composite income | -268.19%-4.25M | -292.31%-5.24M | -97.04%20.52K | -182.16%-4.74M | 81.29%-1.15M | 50.85%-1.34M | 147.32%694.17K | -1,511.80%-1.68M | -441.19%-6.17M | -161.04%-2.72M |
| Other composite income of parent company owners | -1,472.07%-3.24M | -1,800.60%-3.64M | -87.44%22.34K | -541.92%-4.01M | 92.99%-206.24K | 84.90%-191.59K | 36.30%177.83K | 224.51%906.51K | -139.41%-2.94M | -4.33%-1.27M |
| Other composite income of minority owners | -6.22%-1.01M | -39.97%-1.6M | -100.35%-1.82K | 71.48%-738.18K | 70.60%-947.77K | 21.05%-1.15M | 243.76%516.34K | -514.89%-2.59M | -3,680.67%-3.22M | -930.73%-1.45M |
| Total composite income | -1.53%219.08M | 2.78%173.08M | 10.98%78.07M | 25.17%254.76M | 15.05%222.49M | 19.30%168.39M | 3.08%70.35M | 7.09%203.52M | 16.85%193.39M | 13.07%141.15M |
| Total composite income of parent company owners | -3.76%221.12M | 0.08%174.82M | 10.52%79.12M | 26.63%252.55M | 14.59%229.75M | 20.24%174.67M | 2.73%71.59M | 11.56%199.43M | 16.96%200.5M | 10.20%145.28M |
| Total composite income of minority owners | 71.89%-2.04M | 72.29%-1.74M | 15.83%-1.05M | -45.95%2.21M | -2.18%-7.26M | -52.23%-6.28M | 13.94%-1.24M | -63.77%4.09M | -20.16%-7.11M | 41.00%-4.13M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
